Insufficient scRNA-seq data for expression of MAS1 at single-cell level.
Insufficient scRNA-seq data for expression of MAS1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| uterus | 94% | 70.48 | 159 / 170 | 0% | 0.01 | 1 / 459 |
| ovary | 83% | 27.01 | 149 / 180 | 1% | 0.02 | 6 / 430 |
| prostate | 74% | 34.97 | 182 / 245 | 1% | 0.01 | 3 / 502 |
| blood vessel | 62% | 27.46 | 825 / 1335 | 0% | 0 | 0 / 0 |
| brain | 42% | 202.02 | 1110 / 2642 | 10% | 0.24 | 68 / 705 |
| adipose | 46% | 14.93 | 549 / 1204 | 0% | 0 | 0 / 0 |
| stomach | 28% | 6.85 | 100 / 359 | 0% | 0 | 0 / 286 |
| thymus | 26% | 3.96 | 171 / 653 | 0% | 0 | 0 / 605 |
| breast | 24% | 4.23 | 109 / 459 | 0% | 0.00 | 1 / 1118 |
| heart | 24% | 3.35 | 203 / 861 | 0% | 0 | 0 / 0 |
| bladder | 14% | 2.00 | 3 / 21 | 0% | 0 | 0 / 504 |
| muscle | 13% | 1.85 | 108 / 803 | 0% | 0 | 0 / 0 |
| skin | 11% | 1.67 | 191 / 1809 | 2% | 0.13 | 10 / 472 |
| kidney | 8% | 1.08 | 7 / 89 | 0% | 0.01 | 2 / 901 |
| lung | 7% | 0.76 | 43 / 578 | 0% | 0.00 | 1 / 1155 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
| spleen | 3% | 0.31 | 8 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 3% | 0.40 | 29 / 929 | 0% | 0 | 0 / 0 |
| intestine | 3% | 0.39 | 30 / 966 | 0% | 0 | 0 / 527 |
| adrenal gland | 3% | 0.25 | 7 / 258 | 0% | 0 | 0 / 230 |
| esophagus | 2% | 0.37 | 30 / 1445 | 1% | 0.01 | 1 / 183 |
| liver | 2% | 0.14 | 4 / 226 | 0% | 0 | 0 / 406 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.54 | 1 / 80 |
| pancreas | 0% | 0.04 | 1 / 328 | 1% | 0.03 | 1 / 178 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007283 | Biological process | spermatogenesis |
| GO_0021766 | Biological process | hippocampus development |
| GO_0060732 | Biological process | positive regulation of inositol phosphate biosynthetic process |
| GO_0050727 | Biological process | regulation of inflammatory response |
| GO_0014823 | Biological process | response to activity |
| GO_0001933 | Biological process | negative regulation of protein phosphorylation |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0038166 | Biological process | angiotensin-activated signaling pathway |
| GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
| GO_0045740 | Biological process | positive regulation of DNA replication |
| GO_0008584 | Biological process | male gonad development |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0070528 | Biological process | protein kinase C signaling |
| GO_0009410 | Biological process | response to xenobiotic stimulus |
| GO_0034698 | Biological process | response to gonadotropin |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0009986 | Cellular component | cell surface |
| GO_0004930 | Molecular function | G protein-coupled receptor activity |
| GO_0042277 | Molecular function | peptide binding |
| GO_0001595 | Molecular function | angiotensin receptor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0004945 | Molecular function | angiotensin type II receptor activity |
| Gene name | MAS1 |
| Protein name | Proto-oncogene Mas |
| Synonyms | MAS |
| Description | FUNCTION: Receptor for angiotensin 1-7 (By similarity). Acts specifically as a functional antagonist of AGTR1 (angiotensin-2 type 1 receptor), although it up-regulates AGTR1 receptor levels. Positive regulation of AGTR1 levels occurs through activation of the G-proteins GNA11 and GNAQ, and stimulation of the protein kinase C signaling cascade. The antagonist effect on AGTR1 function is probably due to AGTR1 being physically altered by MAS1. . |
| Accessions | ENST00000252660.5 P04201 ENST00000674077.2 |